PedAM
Pediatric Disease Annotations & Medicines
| Disease | lymphoma |
| Phenotype | C0007131|nsclc |
| Sentences | 4 |
| PubMedID- 26253541 | 1representatives of hematoxylin–eosin (h&e) staining and fluorescence in situ hybridization (fish) in non–small cell lung cancer (nsclc) lesions with anaplastic lymphoma kinase (alk) rearrangement. |
| PubMedID- 22465695 | Fluorescence in situ hybridization (fish) is currently used to detect non-small cell lung cancer (nsclc) patients with anaplastic lymphoma kinase (alk) gene rearrangement, who are candidates for alk inhibitor therapy. |
| PubMedID- 26419961 | Non-small cell lung cancer (nsclc) harboring chromosomal rearrangements of the anaplastic lymphoma kinase (alk) gene is treated with alk tyrosine kinase inhibitors (tki), but the treatment is successful for only a limited amount of time; most patients experience a relapse due to the development of drug resistance. |
| PubMedID- 23074683 | Reported a non-hodgkin's lymphoma coexisting with an nsclc, whereas rubiales et al. |
Page: 1